Susannah Lee Chung

Array ( [id] => 7580942 [patent_doc_number] => 20110294825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'POLYMORPHIC FORMS OF 1-\'4-(5-CYANOINDOL-3-YL)BUTYL-4-(2-CARBAMOYLBENZOFURAN-5-YL)PIPERAZINE HYDROCHLORIDE' [patent_app_type] => utility [patent_app_number] => 13/100948 [patent_app_country] => US [patent_app_date] => 2011-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 13960 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294825.pdf [firstpage_image] =>[orig_patent_app_number] => 13100948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574317 [patent_doc_number] => 20110269973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'Process for Preparing Dithiine-tetracarboximides' [patent_app_type] => utility [patent_app_number] => 13/086512 [patent_app_country] => US [patent_app_date] => 2011-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5017 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269973.pdf [firstpage_image] =>[orig_patent_app_number] => 13086512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9059999 [patent_doc_number] => 08546434 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Triazole compounds as KSP inhibitors' [patent_app_type] => utility [patent_app_number] => 13/085746 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21411 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13085746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8543452 [patent_doc_number] => 08318744 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Polymorphic forms of 1-′4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride' [patent_app_type] => utility [patent_app_number] => 13/085117 [patent_app_country] => US [patent_app_date] => 2011-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 46 [patent_no_of_words] => 14088 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13085117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062034 [patent_doc_number] => 20110200553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS' [patent_app_type] => utility [patent_app_number] => 13/081780 [patent_app_country] => US [patent_app_date] => 2011-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46180 [patent_no_of_claims] => 97 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200553.pdf [firstpage_image] =>[orig_patent_app_number] => 13081780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8386213 [patent_doc_number] => 08263608 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Melanocortin receptor-specific spiro-piperidine compounds' [patent_app_type] => utility [patent_app_number] => 13/074070 [patent_app_country] => US [patent_app_date] => 2011-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32707 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13074070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8567456 [patent_doc_number] => 20120330027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'PROCESS FOR THE PREPARATION OF 5-SUBSTITUTED 1-ALKYLTETRAZOLES' [patent_app_type] => utility [patent_app_number] => 13/582026 [patent_app_country] => US [patent_app_date] => 2011-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2731 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13582026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8621496 [patent_doc_number] => 08354410 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-15 [patent_title] => 'Compounds for the treatment of hepatitis C' [patent_app_type] => utility [patent_app_number] => 13/043747 [patent_app_country] => US [patent_app_date] => 2011-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28287 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13043747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7808078 [patent_doc_number] => 20120059032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => '1,2,3,4-TETRAHYDROISOQUINOLINE DERIVATIVES EFFECTIVE AS ANTIGLIOMA AGENTS, METHODS OF MAKING, AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 13/042273 [patent_app_country] => US [patent_app_date] => 2011-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4735 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20120059032.pdf [firstpage_image] =>[orig_patent_app_number] => 13042273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561774 [patent_doc_number] => 20110275607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'NUCLEAR TRANSPORT MODULATORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/041377 [patent_app_country] => US [patent_app_date] => 2011-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 76325 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275607.pdf [firstpage_image] =>[orig_patent_app_number] => 13041377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8555262 [patent_doc_number] => 08329735 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Tetrazole compounds which selectively modulate the CB2 receptor' [patent_app_type] => utility [patent_app_number] => 13/037422 [patent_app_country] => US [patent_app_date] => 2011-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16846 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13037422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490455 [patent_doc_number] => 20110237589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'GUANIDINE COMPOUNDS, AND USE THEREOF AS BINDING PARTNERS FOR 5-HT5 RECEPTORS' [patent_app_type] => utility [patent_app_number] => 13/021336 [patent_app_country] => US [patent_app_date] => 2011-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37955 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237589.pdf [firstpage_image] =>[orig_patent_app_number] => 13021336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055935 [patent_doc_number] => 20110112295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'TRICYCLIC SPACER SYSTEMS FOR NONLINEAR OPTICAL DEVICES' [patent_app_type] => utility [patent_app_number] => 13/007000 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5176 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112295.pdf [firstpage_image] =>[orig_patent_app_number] => 13007000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055749 [patent_doc_number] => 20110112109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'TRIAZOLONE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/006004 [patent_app_country] => US [patent_app_date] => 2011-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 129966 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112109.pdf [firstpage_image] =>[orig_patent_app_number] => 13006004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6178003 [patent_doc_number] => 20110178125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'USE OF GALR3 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF DEPRESSION AND/OR ANXIETY AND COMPOUNDS USEFUL IN SUCH METHODS' [patent_app_type] => utility [patent_app_number] => 12/987217 [patent_app_country] => US [patent_app_date] => 2011-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 27079 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178125.pdf [firstpage_image] =>[orig_patent_app_number] => 12987217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487668 [patent_doc_number] => 20110251194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'ANTINEOPLASTIC DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/986642 [patent_app_country] => US [patent_app_date] => 2011-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19914 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251194.pdf [firstpage_image] =>[orig_patent_app_number] => 12986642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8436083 [patent_doc_number] => 08283855 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-09 [patent_title] => 'Method for synthesis of anthracene derivative' [patent_app_type] => utility [patent_app_number] => 12/985370 [patent_app_country] => US [patent_app_date] => 2011-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 6526 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12985370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9009456 [patent_doc_number] => 08524754 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-03 [patent_title] => 'Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio) acetate, and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/375607 [patent_app_country] => US [patent_app_date] => 2011-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 19590 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13375607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574147 [patent_doc_number] => 20110269803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'AZOLE COMPOUNDS USED AS TUBERCULOSTATIC AND LEISHMANICIDE AGENTS' [patent_app_type] => utility [patent_app_number] => 12/981315 [patent_app_country] => US [patent_app_date] => 2010-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18015 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269803.pdf [firstpage_image] =>[orig_patent_app_number] => 12981315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7988139 [patent_doc_number] => 08076364 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-13 [patent_title] => 'Trisubstituted amine compound' [patent_app_type] => utility [patent_app_number] => 12/973403 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69915 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/076/08076364.pdf [firstpage_image] =>[orig_patent_app_number] => 12973403 [rel_patent_id] =>[rel_patent_doc_number] =>)